Company / Revenue per Share
GeneDx Holdings Corp. Revenue per Share History
FY2019-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Revenue per Share
$15.26
FY2025
5-year range
$11.76 / $1711250.00
FY2021-FY2025
Trend
+29.8%
vs FY2024
Sector context
#94 of 147
Health Care
What the data says
At $15.26, GeneDx Holdings Corp.'s revenue per share ranks #94 of 147 in the Health Care sector. Revenue per Share returned to growth in FY2025 after 3 years of decline, reaching $15.26.
Based on SEC 10-K filings.
15.26 in FY2025 with a 5-year CAGR of -78.7%.
Declined from $17.21 to $15.26 over the past 2 years.
Health Care sector context is included.
Revenue per Share over time
Growth rates
- 3-Year CAGR
- -93.1%
- 5-Year CAGR
- -78.7%
- 10-Year CAGR
- -
Sector benchmark
#94 of 147 in Health CareTop 64% of 147This company $15.26 Sector average $127.83
▼
-88.1% below sector average
Key checks
Key Insights
- In FY2025, revenue per share increased 29.8% year-over-year.
- Ranks #94 out of 147 companies in the Health Care sector.
- Peak revenue per share was recorded in FY2021.
- Lowest revenue per share in the period was in FY2024.
Company context
Key Data Points
- Altman Z-Score -0.67 (distress zone, below 1.8 threshold)
- Negative profit margin: -17.1%
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Revenue per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $15.26 | +29.8% |
| FY2024 | $11.76 | -31.7% |
| FY2023 | $17.21 | -100.0% |
| FY2022 | $45740.40 | -97.3% |
| FY2021 | $1711250.00 | +4796.5% |
| FY2020 | $34948.74 | -97.8% |
| FY2019 | $1582048.39 | - |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026